%0 Journal Article
%T Evaluate the Response Rate of Acute Lymphocytic Leukemia Patients to Hyper Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone Regimen and Remission Rate to Stay Until the End of the Arbitrary Treatment
%A Abbas Ahmadifar
%A Mehdi Mahmoudzadeh
%A Valiollah Mehrzad
%J Archive of "Advanced Biomedical Research".
%D 2018
%R 10.4103/abr.abr_120_16
%X This study aimed to determine the effect of Hyper-Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone (CVAD) in the treatment of acute lymphoblastic leukemia (ALL) patients and remission duration
%K Acute lymphoblastic leukemia
%K Hyper Cyclophosphamide
%K Vincristine
%K Adriamycin
%K and Dexamethasone
%K recurrence
%K survival
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991283/